Crossbow Therapeutics vs Jazz Pharmaceuticals
Crossbow Therapeutics vs Jazz Pharmaceuticals, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crossbow Therapeutics is on 55/100 and Jazz Pharmaceuticals on 24/100.
Where each one leads
Crossbow Therapeutics
- our overall score: 55/100 against 24/100
- agent readiness: 45/100 against 33/100
Jazz Pharmaceuticals
- domain rating: 76/100 against 25/100
- funding raised: $265M against $157M
At a glance
| Measure | Crossbow Therapeutics | Jazz Pharmaceuticals |
|---|---|---|
| What it is | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. | Global biopharmaceutical company focused on oncology and neuroscience treatments. |
| Category | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy | Biotechnology, Pharmaceuticals, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Pharmaceuticals |
| Founded | 2021 | 2003 |
| Headquarters | Cambridge, United States | Dublin, Ireland |
| Status | Active | Active |
Size, funding and growth
| Measure | Crossbow Therapeutics | Jazz Pharmaceuticals |
|---|---|---|
| Employees | 40 | Not published |
| Total funding | $157M | $265M |
| Latest round | Series B | Post IPO |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crossbow Therapeutics | Jazz Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 24/100 |
| Traction | 56/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 15/100 | 6/100 |
| Quality | 65/100 | 15/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | F (33/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 76/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crossbow Therapeutics | Jazz Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Wix | Not detected |
| Frameworks | Not detected | Bootstrap |
| Open source | Yes | Yes |
Crossbow Therapeutics vs Jazz Pharmaceuticals: common questions
Which is better, Crossbow Therapeutics or Jazz Pharmaceuticals?
On our 0-100 score Crossbow Therapeutics rates higher (55/100 against 24/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Crossbow Therapeutics and Jazz Pharmaceuticals compare on the numbers?
Crossbow Therapeutics leads on our overall score (55/100 against 24/100), agent readiness (45/100 against 33/100). Jazz Pharmaceuticals leads on domain rating (76/100 against 25/100), funding raised ($265M against $157M).
Read the full Crossbow Therapeutics review and pricing or the Jazz Pharmaceuticals review and pricing. You can also browse other Crossbow Therapeutics alternatives we track.